Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a variety of previously hard-to-treat diseases, including neurological diseases.
Cholesterol-linked drug boosts gene-targeting potency in early findings
Original Source
This article was collected from: Phys.org
Gabeshana News automatically collects article information
from external RSS/Atom sources. The original article remains
available at the source website. Please visit the original
source for the complete article and the latest information.